Works matching IS 15257304 AND DT 2022 AND VI 23 AND IP 2

Results: 27

Table of Contents.

Published in:: Clinical Lung Cancer, 2022, v. 23, n. 2, p. A3, doi. 10.1016/S1525-7304(22)00025-0
Publication type:: Article

Editorial Board.

Published in:: Clinical Lung Cancer, 2022, v. 23, n. 2, p. A1, doi. 10.1016/s1525-7304(21)00298-9
Publication type:: Article

Safety and Efficacy of Extended Interval Dosing for Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer During the COVID-19 Pandemic.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. 143, doi. 10.1016/j.cllc.2021.12.005

By:

Hijmering-Kappelle, L.B.M.;
Hiltermann, T.J.N;
Bensch, F.

Publication type:

Article

dNLR-Based Score Predicting Overall Survival Benefit for The Addition of Platinum-Based Chemotherapy to Pembrolizumab in Advanced NSCLC With PD-L1 Tumor Proportion Score ≥50%.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. 122, doi. 10.1016/j.cllc.2021.12.006

By:

Holtzman, Liran;
Moskovitz, Mor;
Urban, Damien;
Nechushtan, Hovav;
Keren, Shoshana;
Reinhorn, Daniel;
Wollner, Mira;
Daher, Sameh;
Rottenberg, Yakir;
Rovitzky, Yulia;
Shochat, Tzippy;
Bar, Jair;
Dudnik, Elizabeth

Publication type:

Article

Benefit of Concurrent Versus Sequential Chemoradiotherapy in Elderly Patients With Stage III Non-Small Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. 116, doi. 10.1016/j.cllc.2021.12.004

By:

Logtenberg, Marleen E.;
Tomlow, Ben;
Kastelijn, Elisabeth A.;
Schramel, Franz M.N.H.

Publication type:

Article

Lipoid Pneumonia After Pembrolizumab Treatment for Advanced Non–Small-Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. e116, doi. 10.1016/j.cllc.2021.12.003

By:

Yaga, Moto;
Shiroyama, Takayuki;
Hirata, Haruhiko;
Oya, Kaori;
Takeda, Yoshito;
Kumanogoh, Atsushi

Publication type:

Article

Increased Disparities in Patients Diagnosed with Metastatic Lung Cancer Following Lung CT Screening in the United States.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. 151, doi. 10.1016/j.cllc.2021.11.006

By:

Ganesh, Ashwin;
Katipally, Rohan;
Pasquinelli, Mary;
Feldman, Lawrence;
Spiotto, Michael;
Koshy, Matthew

Publication type:

Article

NaPi2b expression in a large surgical Non-Small Cell Lung Cancer (NSCLC) cohort.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. e90, doi. 10.1016/j.cllc.2021.11.005

By:

Heynemann, S;
Yu, H;
Churilov, L;
Rivalland, G;
Asadi, K;
Mosher, R;
Hirsch, F;
Rivard, C;
Mitchell, P

Publication type:

Article

The new era of immune checkpoint inhibition and target therapy in early-stage non-small cell lung cancer. A review of the literature.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. 108, doi. 10.1016/j.cllc.2021.11.003

By:

Catania, Chiara;
Muthusamy, Bharathi;
Spitaleri, Gianluca;
del Signore, Ester;
Pennell, Nathan A.

Publication type:

Article

Longitudinal Assessment of Health Utility Scores, Symptoms and Toxicities in Patients with Small Cell Lung Cancer Using Real World Data.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. e154, doi. 10.1016/j.cllc.2021.09.006

By:

Kuehne, Nathan;
Hueniken, Katrina;
Xu, Maria;
Shakik, Sharara;
Vedadi, Ali;
Pinto, Dixon;
Brown, M. Catherine;
Bradbury, Penelope A.;
Shepherd, Frances A.;
Sacher, Adrian G.;
Leighl, Natasha B.;
Xu, Wei;
Lok, Benjamin H.;
Liu, Geoffrey;
O'Kane, Grainne M.

Publication type:

Article

Genetic Profiling of Cell-Free DNA From Pleural Effusion in Advanced Lung Cancer as a Surrogate for Tumor Tissue and Revealed Additional Clinical Actionable Targets.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. 135, doi. 10.1016/j.cllc.2021.09.002

By:

Tu, Hai-Yan;
Li, Yang-Si;
Bai, Xiao-Yan;
Sun, Yue-Li;
Zheng, Ming-Ying;
Ke, E-E;
Liao, Ri-Qiang;
Jiang, Ben-Yuan;
Lin, Jia-Xin;
Huang, Jie;
Xu, Bing-Fei;
Yang, Jin-Ji;
Zhang, Xu-Chao;
Zhou, Qing;
Wang, Bin-Chao;
Chen, Hua-Jun;
Tong, Xiaoling;
Yu, Ruoying;
Wu, Xue;
Zhu, Dongqin

Publication type:

Article

Risk Factors for Lung Cancer in an Underrepresented Safety-Net Screening Cohort.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. e165, doi. 10.1016/j.cllc.2021.07.009

By:

Singh, Sarah;
Pavesi, Flaminio;
Steiling, Katrina;
Asokan, Sainath;
Espinosa, Cisco;
Cabral, Howard J.;
Burks, Eric J.;
Meister, Amanda;
Akpoviroro, Ogheneyoma;
Buck, Anne;
Drozdowicz, Kelly;
Litle, Virginia R.;
Suzuki, Kei

Publication type:

Article

Near-Complete Response to Combined Pembrolizumab and Platinum-Doublet in a Patient With STK11/KRAS Mutated Advanced Lung Adenocarcinoma.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. e137, doi. 10.1016/j.cllc.2021.07.007

By:

Pathak, Ranjan;
Salgia, Ravi

Publication type:

Article

Arginase Pathway Markers of Immune-Microenvironment in Thymic Epithelial Tumors and Small Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. e140, doi. 10.1016/j.cllc.2021.07.006

By:

Umemura, Shigeki;
Chen, Vincent;
Chahine, Joeffrey J;
Kallakury, Bhaskar;
Zhao, Xiaoliang;
Lee, Hyun;
Avantaggiati, Maria Laura;
He, Yongfeng;
Wang, Changli;
Giaccone, Giuseppe

Publication type:

Article

Care Patterns for Stereotactic Radiosurgery in Small Cell Lung Cancer Brain Metastases.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. 185, doi. 10.1016/j.cllc.2021.07.003

By:

Gjyshi, Olsi;
Lin, Steven H.;
Pezzi, Todd A.;
Ning, Matthew S.;
Ma, Junsheng;
Liu, Suyu;
Rusthoven, Chad G.

Publication type:

Article

EGFR exon 20 Insertion NSCLC and Response to Platinum-Based Chemotherapy.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. e148, doi. 10.1016/j.cllc.2021.07.001

By:

Shah, Manan P.;
Aredo, Jacqueline V.;
Padda, Sukhmani K.;
Ramchandran, Kavitha J.;
Wakelee, Heather A.;
Das, Millie S.;
Neal, Joel W.

Publication type:

Article

Comments on "Lobe-specific Lymph Node Dissection in Clinical Stage IA Solid-dominant Non-small-cell Lung Cancer: A Propensity Score Matching Study".

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. e135, doi. 10.1016/j.cllc.2021.06.014

By:

Takamori, Shinkichi;
Takada, Kazuki;
Shimokawa, Mototsugu;
Okamoto, Tatsuro

Publication type:

Article

Tumor Shrinkage With Combination of Alectinib and Trastuzumab in a Patient With ALK-Rearranged Non–small Cell Lung Cancer Harboring HER2-Amplification as an Acquired Resistance Mechanism to ALK Inhibitor Therapy.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. e99, doi. 10.1016/j.cllc.2021.06.012

By:

Tsui, David Chun Cheong;
Aisner, Dara;
Nijmeh, Hala;
Bao, Liming;
Menter, Alexander;
Camidge, D. Ross

Publication type:

Article

Actionability of on-target ALK Resistance Mutations in Patients With Non-Small Cell Lung Cancer: Local Experience and Review of the Literature.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. e104, doi. 10.1016/j.cllc.2021.06.011

By:

Koopman, Bart;
Groen, Harry J.M.;
Schuuring, Ed;
Hiltermann, T. Jeroen N.;
Timens, Wim;
den Dunnen, Wilfred F.A.;
van den Berg, Anke;
ter Elst, Arja;
van Kruchten, Michel;
Kluiver, Joost L.;
Hiddinga, Birgitta I.;
Hijmering-Kappelle, Lucie B.M.;
Groves, Matthew R.;
Vilacha, Juliana F.;
van Kempen, Léon C.;
van der Wekken, Anthonie J.

Publication type:

Article

Efficacy and Safety of Combined Brain Radiotherapy and Immunotherapy in Non-Small-Cell Lung Cancer With Brain Metastases: A Systematic Review and Meta-Analysis.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. 95, doi. 10.1016/j.cllc.2021.06.009

By:

Yang, Yin;
Deng, Lei;
Yang, Yufan;
Zhang, Tao;
Wu, Yuqi;
Wang, Luhua;
Bi, Nan

Publication type:

Article

Nomogram Predicting Overall Survival Benefit of Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. 177, doi. 10.1016/j.cllc.2021.06.008

By:

Jacobs, Corbin D.;
Mehta, Kurren;
Gao, Junheng;
Wang, Xiaofei;
Salama, Joseph K.;
Kelsey, Chris R.;
Torok, Jordan A.

Publication type:

Article

VATS Versus Open Lobectomy in Pathological T1 SCLC: A Multi-Center Retrospective Analysis.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. 170, doi. 10.1016/j.cllc.2021.06.007

By:

Xu, Jinming;
He, Tianyu;
Wu, Yihe;
Cao, Jinlin;
Han, Xingpeng;
Liu, Lunxu;
Fu, Xiangning;
Li, Yin;
Li, Xiaofei;
Xu, Lin;
Liu, Yang;
Zhao, Heng;
Liu, Deruo;
Peng, Xin;
Hu, Jian

Publication type:

Article

Dorian Gray Syndrome of Upfront Immunotherapy in Patients With Non–Small-Cell Lung Cancer and High PD-L1 Expression.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. e87, doi. 10.1016/j.cllc.2021.05.012

By:

Hendriks, Lizza E.L.;
Remon, Jordi;
Besse, Benjamin

Publication type:

Article

The Role of Thoracic Surgeon in the Fight Against COVID-19 Pandemic Frontline.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. 91, doi. 10.1016/j.cllc.2021.05.010

By:

Zhou, Yaodong

Publication type:

Article

A Case Report of Successful Treatment With Crizotinib to Overcome Resistance to Osimertinib in an EGFR Mutated Non–Small-Cell Lung Cancer Patient Harboring an Acquired MET Exon 14 Mutation.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. e131, doi. 10.1016/j.cllc.2021.06.002

By:

Pinquie, François;
Cortot, Alexis B.;
Chevalier, Louise-Marie;
Morel, Alain;
Sandrini, Jérémy;
Guguen, Camille;
Morvan, Benjamin;
Molinier, Olivier

Publication type:

Article

Quality of Life in Octogenarians After Lung Resection Compared to Younger Patients.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. e118, doi. 10.1016/j.cllc.2021.05.008

By:

Asemota, Nicole;
Saftic, Igor;
Tsitsias, Thomas;
King, Juliet;
Pilling, John;
Bille, Andrea

Publication type:

Article

Comparative Efficacy and Safety of TKIs Alone or in Combination With Antiangiogenic Agents in Advanced EGFR-Mutated NSCLC as the First-Line Treatment: A Systematic Review and Meta-Analysis.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 2, p. 159, doi. 10.1016/j.cllc.2021.06.001

By:

Zhang, Shuang;
Li, Shuang;
Liu, Jingjing;
Yang, Changliang;
Zhang, Liang;
Bao, Hao;
Cheng, Ying

Publication type:

Article